Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 2, 2006, Pages 267-273

  Kim, Jenney S ^a   Nag, Pratip ^a   Landay, Alan L ^b   Alves, Mario ^c   Cohn, Mardge H ^d   Bremer, James W ^b   Baum, Linda L ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Department of Ambulatory and Community Health   (United States)

Author keywords

Antibody dependent cell mediated cytotoxicity; HIV; Immunoglobulin; Innate immunity; Mucosal immunity; Saliva

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SALIVA; VIRUS TRANSMISSION;

ANTIBODY SPECIFICITY; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; PROSPECTIVE STUDIES; SALIVA; VIRAL LOAD;

EID: 33750076960     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00146.x     Document Type: Article

References (25)

1. Ahmad A & Menezes J (1996) Antibody-dependent cellular cytotoxicity in HIV infections. Faseb J 10: 258-266.
2. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ & Fox PC (1990) Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr 3: 41-48.
3. Banks ND, Kinsey N, Clements J & Hildreth JE (2002) Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. AIDS Res Hum Retroviruses 18: 1197-1205.
4. Baron S, Poast J & Cloyd MW (1999) Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med 159: 303-310.
5. Baron S, Poast J, Richardson CJ, Nguyen D & Cloyd M (2000) Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 181: 498-504.
6. Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE & Baum LL (2002) Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women. J Infect Dis 185: 439-447.
7. Baum LL, Cassutt KJ, Knigge K, Khattri R, Margolick J, Rinaldo C, Kleeberger CA, Nishanian P, Henrard DR & Phair J (1996) HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol 157: 2168-2173.
8. Black KP, Cummins JE Jr & Jackson S (1996) Serum and secretory IgA from HIV-infected individuals mediate antibody-dependent cellular cytotoxicity. Clin Immunol Immunopathol 81: 182-190.
9. Broliden K, Hinkula J, Devito C, Kiama P, Kimani J, Trabbatoni D, Bwayo JJ, Clerici M, Plummer F & Kaul R (2001) Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol Lett 79: 29-36.
10. Cartry O, Moja P, Quesnel A, Pozzetto B, Lucht FR & Genin C (1997) Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 109: 47-53.
11. Challacombe SJ & Sweet SP (2002) Oral mucosal immunity and HIV infection: current status. Oral Dis 8 (Suppl 2), 55-62.
12. Forthal DN, Landucci G & Daar ES (2001a) Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 75: 6953-6961.
13. Forthal DN, Landucci G & Keenan B (2001b) Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD41 lymphocyte count. AIDS Res Hum Retroviruses 17: 553-561.
14. Holmgren J, Czerkinsky C, Lycke N & Svennerholm AM (1992) Mucosal immunity: implications for vaccine development. Immunobiology 184: 157-179.
15. Jewett A, Giorgi JV & Bonavida B (1990) Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. J Immunol 145: 4065-4071.
16. Lanier LL, Le AM, Civin C, Loken MR & Phillips JH (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 13: 4480-4486.
17. Lopez AF, Begley G, Andrews P, Butterworth AE & Vadas MA (1985) Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis. J Immunol 134: 3969-3977.
18. Morrier JJ & Barsotti O (1990) Secretory IgA and the oral cavity: general review. Actual Odontostomatol (Paris) 44: 349-364.
19. Nag P, Kim J, Sapiega Vet al. (2004) Women with cervico-vaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis 190: 1970-1978.
20. Pross HF & Maroun JA (1984) The standardization of NK cell assays for use in studies of biological response modifiers. J Immunol Methods 68: 235-249.
21. Roberts RL, Aroda VR & Ank BJ (1995) N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients. J Infect Dis 172: 1492-1502.
22. Rozsnyay Z, Sarmay G,Walker M, Maslanka K, Valasek Z, Jefferis R & Gergely J (1989) Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions. Immunology 66: 491-498.
23. Shugars DC & Wahl SM (1998) The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 129: 851-858.
24. Skott P, Lucht E, Julander I, Dillner J & Bjorling E (1999) Salivary sIgA response in HIV-1 infection. J Acquir Immune Defic Syndr 21: 73-80.
25. Toro MJ, Escalona L, Chaiyarit P, Warner NA & Gregory RL (2001) Salivary immunoglobulin A antibodies to gp41 in human immunodeficiency virus-seropositive patients: lack of correlation with disease progression. Oral Microbiol Immunol 16: 188-192.